Free Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy

BACKGROUND: Rhodium (II) citrate (Rh(2)(H(2)cit)(4)) has significant antitumor, cytotoxic, and cytostatic activity on Ehrlich ascite tumor. Although toxic to normal cells, its lower toxicity when compared to carboxylate analogues of rhodium (II) indicates Rh(2)(H(2)cit)(4 )as a promising agent for c...

Descripción completa

Detalles Bibliográficos
Autores principales: Carneiro, Marcella LB, Nunes, Eloiza S, Peixoto, Raphael CA, Oliveira, Ricardo GS, Lourenço, Luiza HM, da Silva, Izabel CR, Simioni, Andreza R, Tedesco, Antônio C, de Souza, Aparecido R, Lacava, Zulmira GM, Báo, Sônia N
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073883/
https://www.ncbi.nlm.nih.gov/pubmed/21443799
http://dx.doi.org/10.1186/1477-3155-9-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073883/
https://www.ncbi.nlm.nih.gov/pubmed/21443799
http://dx.doi.org/10.1186/1477-3155-9-11

Ejemplares similares